arrow
C

Caroline Bret

CNRS
H指数:17
被引数:1,497

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CD200 is a potent new growth factor in Multiple Myeloma dependent on IGF1 receptor signaling

CD200是一种依赖于IGF1受体信号传导的多发性骨髓瘤新型强效生长因子

2026-08-280
OAAI
Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHL

患者来源的淋巴瘤球体揭示了Glofitamab耐药性的预测标志物在复发/难治性B-NHL中

Blood
IF23.1
2026-03-020
PRE
MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors

MCM8和MCM9缺乏导致终生的造血DNA损伤增加,进而驱动p53依赖性髓系肿瘤的发生。

2025-12-180
OAAI
Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell Lymphoma

合成致死组合:DNA修复抑制剂与基因毒性剂的联用,靶向高风险弥漫性大B细胞淋巴瘤

2025-08-230
OAAI
CD200 immune checkpoint expression is associated with inferior outcome in multiple myeloma patients treated with anti-CD38 monoclonal antibodies

CD200免疫检查点表达与接受抗CD38单克隆抗体治疗的骨髓瘤患者不良预后相关

2025-07-200
OA
Ironomycin induces mantle cell lymphoma cell death by targeting iron metabolism addiction

Ironomycin通过靶向铁代谢依赖性诱导套细胞淋巴瘤细胞死亡

2025-02-030
OA
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry
2024-06-202
OAAI
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
2019-12-2389
OA